Integrated molecular drivers coordinate biological and clinical states in melanoma.

导出 OA

翻译打印收藏纠错

作者： Jake R,Conway ^[1] ; Felix,Dietlein ^[2] ; Amaro,Taylor-Weiner ^[3] ; Saud,AlDubayan ^[2] ; Natalie,Vokes ^[3] ; Tanya,Keenan ^[1] ; Brendan,Reardon ^[2] ; Meng Xiao,He ^[3] ; Claire A,Margolis ^[2] ; Jason L,Weirather ^[3] ; Rizwan,Haq ^[4] ; Bastian,Schilling ^[5] ; F,Stephen Hodi ^[2] ; Dirk,Schadendorf ^[3] ; David,Liu ^[2] ; Eliezer M,Van Allen ^[3]

作者单位： Division of Medical Sciences, Harvard University, Boston, MA, USA. ^[1] Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. ^[2] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. ^[3] Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA. ^[4] Department of Medicine, King Saud bin Abdul-Aziz University for Health Sciences, Riyadh, Saudi Arabia. ^[5] Harvard Graduate Program in Biophysics, Boston, MA, USA. ^[6] Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA, USA. ^[7] Department of Dermatology, University Hospital Würzburg, Würzburg, Germany. ^[8] Department of Dermatology, University Hospital, Essen, Germany. ^[9] German Cancer Consortium of Translational Cancer Research, German Cancer Research Center, Heidelberg, Germany. ^[10] Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. EliezerM_VanAllen@dfci.harvard.edu. ^[11] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. EliezerM_VanAllen@dfci.harvard.edu. ^[12] Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA, USA. EliezerM_VanAllen@dfci.harvard.edu. ^[13]